# ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation

> **NCT03504761** · NA · UNKNOWN · sponsor: **Precision Biopsy, Inc.** · enrollment: 325 (estimated)

## Conditions studied

- Cellular Diagnosis, Prostate Cancer

## Interventions

- **DEVICE:** ClariCore Optical Biopsy System

## Key facts

- **NCT ID:** NCT03504761
- **Lead sponsor:** Precision Biopsy, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-25
- **Primary completion:** 2020-01
- **Final completion:** 2020-12
- **Target enrollment:** 325 (ESTIMATED)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03504761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03504761, "ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03504761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*